Molecular devices wins patent case in Europe
Molecular Devices, LLC announced that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in its original form, following a recent Opposition Proceeding.
Molecular Devices’ patent went through Opposition Proceedings before the Opposition Division of the European Patent Office as a result of a challenge from an analytical instrument company. The European Patent Office concluded that Molecular Devices’ patent, whose claims are directed to systems and methods of making high-throughput electrophysiological measurements, is valid as originally issued.
“Our robust portfolio of over 300 issued patents and numerous pending patent applications are proof of our commitment to develop new and meaningful workflow solutions enabling landmark scientific achievements. We will continue to invest in and defend our intellectual property.” said Greg Milosevich, President of Molecular Devices.
“We are delighted that the Opposition Division has acknowledged the inventive concept of this technology. We are determined to protect the intellectual property assets that cover our unique technology from any challenge,” Milosevich concluded.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
